Survey on the Impact of the COVID-19 Pandemic on Patients with Parkinson’s Disease and Their Caregivers in Japan

References

• Ferini-Strambi L, Salsone M. COVID-19 and neurological disorders: are neurodegenerative or neuroimmunological diseases more vulnerable? J Neurol. 2021;268(2):409–419. doi:10.1007/s00415-020-10070-8
   PubMed Web of Science ®Google Scholar
• Bhidayasiri R, Virameteekul S, Kim JM, Pal PK, Chung SJ. COVID-19: an early review of its global impact and considerations for Parkinson’s disease patient care. J Mov Disord. 2020;13(2):105–114. doi:10.14802/jmd.20042
   PubMed Web of Science ®Google Scholar
• Prasad S, Holla VV, Neeraja K, et al. Parkinson’s disease and COVID-19: perceptions and implications in patients and caregivers. Mov Disord. 2020;35(6):912–914. doi:10.1002/mds.28088
   PubMed Web of Science ®Google Scholar
• Schirinzi T, Cerroni R, Di Lazzaro G, et al. Self-reported needs of patients with Parkinson’s disease during COVID-19 emergency in Italy. Neurol Sci. 2020;41(6):1373–1375. doi:10.1007/s10072-020-04442-1
   PubMed Web of Science ®Google Scholar
• Shalash A, Roushdy T, Essam M, et al. Mental health, physical activity, and quality of life in Parkinson’s disease during COVID-19 pandemic. Mov Disord. 2020;35(7):1097–1099. doi:10.1002/mds.28134
   PubMed Web of Science ®Google Scholar
• Brown EG, Chahine LM, Goldman SM, et al. The effect of the COVID-19 pandemic on people with Parkinson’s disease. J Parkinsons Dis. 2020;10(4):1365–1377. doi:10.3233/JPD-202249
   PubMedGoogle Scholar
• Helmich RC, Bloem BR. The impact of the COVID-19 pandemic on Parkinson’s disease: hidden sorrows and emerging opportunities. J Parkinsons Dis. 2020;10(2):351–354. doi:10.3233/JPD-202038
   PubMedGoogle Scholar
• Kumar N, Gupta R, Kumar H, et al. Impact of home confinement during COVID-19 pandemic on Parkinson’s disease. Parkinsonism Relat Disord. 2020;80:32–34. doi:10.1016/j.parkreldis.2020.09.003
   PubMed Web of Science ®Google Scholar
• Zipprich HM, Teschner U, Witte OW, Schönenberg A, Prell T. Knowledge, attitudes, practices, and burden during the COVID-19 pandemic in people with Parkinson’s disease in Germany. J Clin Med. 2020;9(6):1643. doi:10.3390/jcm9061643
   PubMed Web of Science ®Google Scholar
• Palermo G, Tommasini L, Baldacci F, Del Prete E, Siciliano G, Ceravolo R. Impact of coronavirus disease 2019 pandemic on cognition in Parkinson’s disease. Mov Disord. 2020;35(10):1717–1718.
   PubMed Web of Science ®Google Scholar
• van der Heide A, Meinders MJ, Bloem BR, Helmich RC. The impact of the COVID-19 pandemic on psychological distress, physical activity, and symptom severity in Parkinson’s disease. J Parkinsons Dis. 2020;10(4):1355–1364. doi:10.3233/JPD-202251
   PubMedGoogle Scholar
• Hanff AM, Pauly C, Pauly L, et al. Unmet needs of people with Parkinson’s disease and their caregivers during COVID-19-related confinement: an explorative secondary data analysis. Front Neurol. 2021;11:615172. doi:10.3389/fneur.2020.615172
   PubMed Web of Science ®Google Scholar
• Schrag A, Hovris A, Morley D, Quinn N, Jahanshahi M. Caregiver-burden in Parkinson’s disease is closely associated with psychiatric symptoms, falls, and disability. Parkinsonism Relat Disord. 2006;12(1):35–41. doi:10.1016/j.parkreldis.2005.06.011
   PubMed Web of Science ®Google Scholar
• Martínez-Martín P, Forjaz MJ, Frades-Payo B, et al. Caregiver burden in Parkinson’s disease. Mov Disord. 2007;22(7):924–931; quiz 1060. doi:10.1002/mds.21355
   PubMed Web of Science ®Google Scholar
• von Eichel H, Heine J, Wegner F, et al. Neuropsychiatric symptoms in Parkinson’s disease patients are associated with reduced health-related quality of life and increased caregiver burden. Brain Sci. 2022;12(1):89. doi:10.3390/brainsci12010089
   PubMed Web of Science ®Google Scholar
• Klietz M, Schnur T, Drexel S, et al. Association of motor and cognitive symptoms with health-related quality of life and caregiver burden in a German cohort of advanced Parkinson’s disease patients. Parkinsons Dis. 2020;2020:5184084. doi:10.1155/2020/5184084
   PubMed Web of Science ®Google Scholar
• De Micco R, Siciliano M, Sant’Elia V, et al. Correlates of psychological distress in patients with Parkinson’s disease during the COVID-19 outbreak. Mov Disord Clin Pract. 2020;8(1):60–68. doi:10.1002/mdc3.13108
   PubMed Web of Science ®Google Scholar
• Oppo V, Serra G, Fenu G, et al. Parkinson’s disease symptoms have a distinct impact on caregivers’ and patients’ stress: a study assessing the consequences of the COVID-19 lockdown. Mov Disord Clin Pract. 2020;7(7):865–867. doi:10.1002/mdc3.13030
   PubMed Web of Science ®Google Scholar
• Kitani-Morii F, Kasai T, Horiguchi G, et al. Risk factors for neuropsychiatric symptoms in patients with Parkinson’s disease during COVID-19 pandemic in Japan. PLoS One. 2021;16(1):e0245864. doi:10.1371/journal.pone.0245864
   PubMed Web of Science ®Google Scholar
• Suzuki K, Numao A, Komagamine T, et al. Impact of the COVID-19 pandemic on the quality of life of patients with Parkinson’s disease and their caregivers: a single-center survey in Tochigi prefecture. J Parkinsons Dis. 2021;11(3):1047–1056. doi:10.3233/JPD-212560
   PubMedGoogle Scholar
• Subramanian I, Farahnik J, Mischley LK. Synergy of pandemics-social isolation is associated with worsened Parkinson severity and quality of life. NPJ Parkinsons Dis. 2020;6(1):28. doi:10.1038/s41531-020-00128-9
   PubMed Web of Science ®Google Scholar
• Terwee CB, Bot SD, de Boer MR, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60(1):34–42. doi:10.1016/j.jclinepi.2006.03.012
   PubMed Web of Science ®Google Scholar
• Ministry of Health, Labour and Welfare. Administrative notice: temporary and exceptional online medical examination under COVID-19 pandemic [In Japanese]. Available from: https://www.mhlw.go.jp/content/000620995.pdf. Accessed September 30.
   Google Scholar
• Feeney MP, Xu Y, Surface M, et al. The impact of COVID-19 and social distancing on people with Parkinson’s disease: a survey study. NPJ Parkinsons Dis. 2021;7(1):10. doi:10.1038/s41531-020-00153-8
   PubMedGoogle Scholar
• Kurihara K, Nagaki K, Inoue K, et al. Attitudes toward telemedicine of patients with Parkinson’s disease during the COVID-19 pandemic. Neurol Clin Neurosci. 2021;9(1):77–82. doi:10.1111/ncn3.12465
   Web of Science ®Google Scholar
• Hassan A, Mari Z, Gatto EM, et al. Global survey on telemedicine utilization for movement disorders during the COVID-19 pandemic. Mov Disord. 2020;35(10):1701–1711. doi:10.1002/mds.28284
   PubMed Web of Science ®Google Scholar
• Osada T, Deguchi I, Arai N, et al. Needs for online care of Parkinson’s patients in the Covid-19 epidemic [In Japanese]. Paper presented at: Proceedings of the 15th Parkinson’s Disease, Movement Disorders Congress; July 1–3; 2021; Sendai, Japan.
   Google Scholar
• Piano C, Bove F, Tufo T, et al. Effects of COVID-19 lockdown on movement disorders patients with deep brain stimulation: a multicenter survey. Front Neurol. 2020;11:616550. doi:10.3389/fneur.2020.616550
   PubMed Web of Science ®Google Scholar
• Salari M, Zali A, Ashrafi F, et al. Incidence of anxiety in Parkinson’s disease during the coronavirus disease (COVID-19) pandemic. Mov Disord. 2020;35(7):1095–1096. doi:10.1002/mds.28116
   PubMed Web of Science ®Google Scholar
• Lo Monaco MR, Di Stasio E, Ricciardi D, et al. What about the caregiver? A journey into Parkinson’s disease following the burden tracks. Aging Clin Exp Res. 2021;33(4):991–996. doi:10.1007/s40520-020-01600-5
   PubMed Web of Science ®Google Scholar
• Grün D, Pieri V, Vaillant M, Diederich NJ. Contributory factors to caregiver burden in Parkinson disease. J Am Med Dir Assoc. 2016;17(7):626–632. doi:10.1016/j.jamda.2016.03.004
   PubMed Web of Science ®Google Scholar
• Macchi ZA, Ayele R, Dini M, et al. Lessons from the COVID-19 pandemic for improving outpatient neuropalliative care: a qualitative study of patient and caregiver perspectives. Palliat Med. 2021;35(7):1258–1266. doi:10.1177/02692163211017383
   PubMed Web of Science ®Google Scholar
• Yoritaka A, Shimo Y, Hatano T, Hattori N. Motor/nonmotor symptoms and progression in patients with Parkinson’s disease: prevalence and risks in a longitudinal study. Parkinsons Dis. 2020;2020:2735361. doi:10.1155/2020/2735361
   PubMed Web of Science ®Google Scholar
• Fujimoto K, Murata M, Hattori N, Kondo T. Patients’ perspective on Parkinson disease therapies: results of a large-scale survey in Japan [In Japanese]. Brain Nerve. 2011;63(3):255–265.
   PubMedGoogle Scholar
• Tsugawa J, Onozawa R, Fukae J, Mishima T, Fujioka S, Tsuboi Y. Impact of insufficient drug efficacy of antiparkinson agents on patient’s quality of life: a cross-sectional study. BMC Neurol. 2015;15:105. doi:10.1186/s12883-015-0360-y
   PubMed Web of Science ®Google Scholar
• Onozawa R, Tsugawa J, Tsuboi Y, Fukae J, Mishima T, Fujioka S. The impact of early morning off in Parkinson’s disease on patient quality of life and caregiver burden. J Neurol Sci. 2016;364:1–5. doi:10.1016/j.jns.2016.02.066
   PubMed Web of Science ®Google Scholar